The American College of Artificial Intelligence and Medicine

Melvin Speisman

The mission of Doctors Melvin Speisman MD, FACP and Ann Slasuratis FACP is to educate and mentor current and next generation physicians on the intersections of artificial intelligence and medicine via research, teaching, hands on patient care, leadership, scholarships, and volunteerism by way of the American College of Artificial Intelligence and Medicine, their own 501c3 organization. This podcast hopes to spread awareness and educate others as to how the wonders of modern technology are shaping the future of health care forever.

  1. Ai in Oncology with Dr Caroline Chung from AMCAIM Scientific Session 2025

    10月6日

    Ai in Oncology with Dr Caroline Chung from AMCAIM Scientific Session 2025

    Recorded September 19, 2025. Today’s speaker from our inaugural Scientific Session of The American College of Ai and Medicine is Dr. Caroline Chung, a leader at the forefront of data science and oncology. She serves as Vice President, Chief Data & Analytics Officer, and Co-Director of the Institute for Data Science in Oncology at MD Anderson Cancer Center. A tenured professor in both Radiation Oncology and Diagnostic Imaging, Dr. Chung combines her clinical expertise in central nervous system cancers with pioneering research in computational imaging. Her work focuses on using advanced quantitative imaging and modeling to better detect and characterize tumors and treatment effects—laying the foundation for more personalized, data-driven cancer care. She leads major institutional efforts like the Tumor Measurement Initiative, aimed at transforming how clinical data is measured, interpreted, and applied through collaborative team science. On the global stage, Dr. Chung plays a key role in shaping standards for quantitative imaging and AI in medicine. She co-chairs several influential committees and coalitions, including groups within the International Commission on Radiation Units and Measurements, the Quantitative Medical Imaging Coalition, and the American Society of Clinical Oncology’s AI Community of Practice. She’s also contributed to national strategy through her service on National Academies and NIH advisory committees focused on digital twins and artificial intelligence. www.AmericanCollegeAIM.org

    57 分钟
  2. Ai and Neurology: A Lecture to Harvard University with Mel Speisman MD and Ann Slasuraitis MD

    8月18日

    Ai and Neurology: A Lecture to Harvard University with Mel Speisman MD and Ann Slasuraitis MD

    Dr. Mel Speisman specializes in Academic Internal Medicine. He is an expert in the diagnosis and treatment of hypertension, diabetes, congestive heart failure, atrial fibrillation, coronary artery disease, stroke, and other chronic medical conditions. He is interested in the primary prevention of disease with a passion for medical education and bedside teaching. He has received numerous awards from medical students and residents during his 25 year career as a core faculty member of an internal medicine residency program. Dr. Speisman has mentored many physicians to take on leadership roles in academic internal medicine. Mel is a lifetime member of Alpha Omega Alpha Honor Medical Society signifying his lifelong commitment to outstanding patient care, professionalism, leadership, scholarship, research, teaching, and community service. In 2024, Mel completed certification programs in Artificial Intelligence and Healthcare at both Harvard Medical School and Massachusetts Institute of Technology as well as a certification in Artificial Intelligence from Northwestern University Kellogg School of Management. Mel is currently enrolled in the Stanford Artificial Intelligence in Health care Certificate Program with the goal of becoming a world leader at the intersection of AI and Medicine. Mel is a Fellow of the American College of Physicians (FACP) and a Fellow of Artificial Intelligence and Medicine (FAIM). In August 2024, he transitioned from being an Assistant Professor in the Division of Academic Internal Medicine at the University Illinois at Chicago College of Medicine to taking a position as President of the American College of Artificial Intelligence and Medicine. Dr. Ann Slasuraitis has been an Academic Internal Medicine hospitalist and core faculty member of an Internal Medicine residency program for over 20 years. During this time, she was involved with undergraduate, graduate, and continuing medical education as the Director for Continuing Medical Education (CME). She has mentored hundreds of medical students and internal medicine residents and has received numerous teaching awards. Currently, she provides primary care to adults with autism at the Ann Kiley Developmental Center and is the Medical Director of the Rimland Center for Autism Research. Dr. Slasuraitis is a Fellow of the American College of Physicians (FACP) and a Fellow of Artificial Intelligence and Medicine (FAIM). In 2023, Ann received the ACP Illinois Outstanding Women Physician Award. In August 2024, she accepted a position as the Executive Vice President of the American College of Artificial Intelligence and Medicine. Dr. Slasuraitis is committed to life-long learning and in our ever-changing medical profession, she is passionate about educating the current and next generation physicians about artificial intelligence and medicine. Dr. Slasuraitis is currently enrolled in the Stanford Artificial Intelligence in Health care Certificate Program. www.AmericanCollegeAim.org

    1 小时 1 分钟
  3. Ai and Medicine, Medical Education, and Pathology with Hooman Rashidi MD

    6月23日

    Ai and Medicine, Medical Education, and Pathology with Hooman Rashidi MD

    Hooman H. Rashidi MD, MS, FCAP Associate Dean of AI in Medicine, Professor & Endowed Chair of Lombardi-Shinozuka Experimental Pathology Research at University of Pittsburgh School of Medicine, Executive Vice Chair of Computational Pathology & Informatics Division at UPMC, Executive Director of CPACE (Computational Pathology & AI Center of Excellence) Dr. Rashidi combines his passion for patient care, research and education with his unique training in bioinformatics and machine learning (ML) to create innovative new tools (i.e. MILO, STNG, Pitt-GPT+, WSI-Genie, Nebulon-GPT, etc.) and resources (Hematology Outlines, Cleveland Clinic's AI course, etc.) that improve clinical practice, research and education. His experience in AI/ML dates back to his graduate years at UCSD which subsequently allowed him to serve as the principal author and editor of several popular bioinformatics textbooks. This background has also enabled him to develop various novel AI-ML platforms. He is currently the Associate Dean of AI in Medicine, Professor & Endowed Chair of Lombardi-Shinozuka Experimental Pathology Research at the University of Pittsburgh School of Medicine, Executive Director of CPACE (Computational Pathology & AI Center of Excellence) and the Executive Vice Chair of the Computational Pathology & Informatics Division at UPMC. He is also Adjunct Professor of Engineering at the Carnegie Mellon University. Before joining University Pittsburgh / UPMC, he served as the founding director of Cleveland Clinic’s Center for Diagnostics & Artificial Intelligence & Vice Chair of Technology Innovation & Computational Pathology, and before that he served as the Director of AI for University of California Davis Medical Center and Professor & Vice chair of informatics, leading a large number of AI studies with numerous collaborators from various prominent institutions. These experiences and studies have also led to the invention of numerous products (most recent of which being the on-prem LLM framework Pitt-GPT+, the automated Image analytics frameworks WSI Genie and Auto-Pix AI) & several filed patents/established products (e.g. the University of California IP MILO: Machine Intelligence Learning Optimizer, the proprietary Automated ML platform & it’s suite of 6 complimentary separate unique Data Science and Statistics Apps & Cleveland Clinic’s new automated synthetic data generator and Validation platform STNG, Synthetic Tabular Neural Generator) along with a large number of manuscripts in which he serves as corresponding author. These products have also been licensed to several industry and academic institutions & serving as a powerful suite of data science tools for a large number of clinical, quality, research and educational projects while also starting to help optimize and expedite data access needs for all investigators. In addition to the above, Dr. Rashidi is also a practicing physician (board certified hematopathologist) and a well-known educator with numerous teaching awards who has created some of the AppStore’s most popular hematology Apps along with Cleveland Clinic’s most recent AI-ML course (launched Cleveland Clinic wide in Jan 2024). He is also the co-founder and senior editor of HematologyOutlines, a very popular digital hematology atlas that is used internationally and endorsed by the American Society of Clinical Pathology.

    53 分钟
  4. Ai is Leveling the Medical Playing Field with Justin Ramsaran

    5月26日

    Ai is Leveling the Medical Playing Field with Justin Ramsaran

    Justin Ramsaran is 30 Under 30 Nominee and an American digital health developer and entrepreneur who leverages cross-functional business strategies and digital transformation with artificial intelligence to empower individuals and advance healthcare systems. He is the CEO of R Group, a digital healthcare innovation company focused on developing next-generation clinical data systems to support future healthcare providers. Additionally, he serves as the VP of Digital Health Solutions for Fukuda Denshi, a Japanese medical device manufacturer dedicated to "transforming world-class technology into accessible healthcare for everyone." Justin is currently a doctoral candidate at Florida Tech, working on his dissertation at NYU Stern. At Florida Tech, he began developing the concept of integrating cross-functional business organization strategies from fintech, big tech, and Al companies into the healthcare system through an "Open Connected Architecture." In parallel, Justin continues to apply these cross-functional business strategies to other industries, including higher education and sports technology. Manifesto: Augment Human Learning with Machine Learning: Especially for social good.Utilize Unconventional Approaches to Complex Problems: Develop simple solutions.While these two ideas may seem disparate, they are interdependent. Humans often hold false notions about the world and encounter misinformation, yet we excel in learning within noisy environments. Augmenting human learning with machine learning requires a deeper understanding of learning in such environments. Across healthcare, agriculture, politics, economics, and transportation, our future as a species relies on the increasing synergy between machine learning and human learning. It is paramount that we develop tools to handle real-world uncertainty while ensuring our advancements in machine intelligence are directed towards social good. www.AmericancollegeAim.org

    33 分钟

评分及评论

5
共 5 分
5 个评分

关于

The mission of Doctors Melvin Speisman MD, FACP and Ann Slasuratis FACP is to educate and mentor current and next generation physicians on the intersections of artificial intelligence and medicine via research, teaching, hands on patient care, leadership, scholarships, and volunteerism by way of the American College of Artificial Intelligence and Medicine, their own 501c3 organization. This podcast hopes to spread awareness and educate others as to how the wonders of modern technology are shaping the future of health care forever.

你可能还喜欢